Technology Spotlight: Manufacturing Cell Therapy Products – Current and Future Challenges
Conference Recording Mar 08, 2013
About the SpeakerInternational biotechnology manager with 16 years of experience in cell therapy/regenerative medicine, managing projects ranging from early R&D to production, regulatory and clinical trials resulting, for example, in market approval for tissue engineered products in the EU.
Cell therapy products are currently manufactured in semi-manual processes. These are suitable to provide product for clinical trials and early commercialization phases. Beyond this, cell therapy products will have to be manufactured and processed in truly scalable systems and Lonza is developing such processes.
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018
EMBL Course: Brillouin Microscopy: Emerging Tool for Probing Mechanical Properties of Living Cells
Jan 17 - Jan 19, 2018